Table 1.
Clinicopathological Features | Total | PD-L1 Expression | P value | |
---|---|---|---|---|
Negative | Positive | |||
Gender | 0.610 | |||
Male | 90 | 50 | 40 | |
Female | 5 | 3 | 2 | |
Age (years) | 0.263 | |||
<60 | 58 | 35 | 23 | |
>60 | 37 | 18 | 19 | |
Differentiation | 0.949 | |||
High-moderate | 63 | 35 | 28 | |
Poor | 32 | 18 | 14 | |
T stage | 0.670 | |||
T1–T2 | 20 | 12 | 8 | |
T3–T4 | 75 | 41 | 34 | |
N stage | <0.001 | |||
N0 | 22 | 20 | 2 | |
N+ | 73 | 33 | 40 | |
Clinical stage | <0.001 | |||
I–II | 9 | 9 | 0 | |
III–IV | 86 | 44 | 42 | |
Distant metastasis | <0.001 | |||
No | 66 | 47 | 19 | |
Yes | 29 | 6 | 23 |
Abbreviations: PD-L1, programmed death-ligand 1; HSCC, hypopharyngeal squamous cell carcinoma.